These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 27053113)

  • 21. Disease-associated mutations in inositol 1,4,5-trisphosphate receptor subunits impair channel function.
    Terry LE; Alzayady KJ; Wahl AM; Malik S; Yule DI
    J Biol Chem; 2020 Dec; 295(52):18160-18178. PubMed ID: 33093175
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeting Bcl-2 based on the interaction of its BH4 domain with the inositol 1,4,5-trisphosphate receptor.
    Rong YP; Barr P; Yee VC; Distelhorst CW
    Biochim Biophys Acta; 2009 Jun; 1793(6):971-8. PubMed ID: 19056433
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Angiotensin II-induced down-regulation of inositol trisphosphate receptors in WB rat liver epithelial cells. Evidence for involvement of the proteasome pathway.
    Bokkala S; Joseph SK
    J Biol Chem; 1997 May; 272(19):12454-61. PubMed ID: 9139693
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cryo-EM structure of human type-3 inositol triphosphate receptor reveals the presence of a self-binding peptide that acts as an antagonist.
    Azumaya CM; Linton EA; Risener CJ; Nakagawa T; Karakas E
    J Biol Chem; 2020 Feb; 295(6):1743-1753. PubMed ID: 31915246
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeting Bcl-2-IP
    Distelhorst CW
    Biochim Biophys Acta Mol Cell Res; 2018 Nov; 1865(11 Pt B):1795-1804. PubMed ID: 30053503
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Constitutive IP
    Bittremieux M; La Rovere RM; Akl H; Martines C; Welkenhuyzen K; Dubron K; Baes M; Janssens A; Vandenberghe P; Laurenti L; Rietdorf K; Morciano G; Pinton P; Mikoshiba K; Bootman MD; Efremov DG; De Smedt H; Parys JB; Bultynck G
    Cell Death Differ; 2019 Mar; 26(3):531-547. PubMed ID: 29899382
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Unique Regulatory Properties of Heterotetrameric Inositol 1,4,5-Trisphosphate Receptors Revealed by Studying Concatenated Receptor Constructs.
    Chandrasekhar R; Alzayady KJ; Wagner LE; Yule DI
    J Biol Chem; 2016 Mar; 291(10):4846-60. PubMed ID: 26755721
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bcl-2 regulation of the inositol 1,4,5-trisphosphate receptor and calcium signaling in normal and malignant lymphocytes: potential new target for cancer treatment.
    Greenberg EF; Lavik AR; Distelhorst CW
    Biochim Biophys Acta; 2014 Oct; 1843(10):2205-10. PubMed ID: 24642270
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Mysteries around the BCL-2 Family Member BOK.
    Shalaby R; Flores-Romero H; García-Sáez AJ
    Biomolecules; 2020 Dec; 10(12):. PubMed ID: 33291826
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tracing the evolutionary history of Ca
    Rosa N; Shabardina V; Ivanova H; Sebé-Pedrós A; Yule DI; Bultynck G
    Biochim Biophys Acta Mol Cell Res; 2021 Nov; 1868(12):119121. PubMed ID: 34400171
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bcl-2 functionally interacts with inositol 1,4,5-trisphosphate receptors to regulate calcium release from the ER in response to inositol 1,4,5-trisphosphate.
    Chen R; Valencia I; Zhong F; McColl KS; Roderick HL; Bootman MD; Berridge MJ; Conway SJ; Holmes AB; Mignery GA; Velez P; Distelhorst CW
    J Cell Biol; 2004 Jul; 166(2):193-203. PubMed ID: 15263017
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The trans-membrane domain of Bcl-2α, but not its hydrophobic cleft, is a critical determinant for efficient IP3 receptor inhibition.
    Ivanova H; Ritaine A; Wagner L; Luyten T; Shapovalov G; Welkenhuyzen K; Seitaj B; Monaco G; De Smedt H; Prevarskaya N; Yule DI; Parys JB; Bultynck G
    Oncotarget; 2016 Aug; 7(34):55704-55720. PubMed ID: 27494888
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeting Bcl-2-IP3 receptor interaction to reverse Bcl-2's inhibition of apoptotic calcium signals.
    Rong YP; Aromolaran AS; Bultynck G; Zhong F; Li X; McColl K; Matsuyama S; Herlitze S; Roderick HL; Bootman MD; Mignery GA; Parys JB; De Smedt H; Distelhorst CW
    Mol Cell; 2008 Jul; 31(2):255-65. PubMed ID: 18657507
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The BH4 domain of anti-apoptotic Bcl-XL, but not that of the related Bcl-2, limits the voltage-dependent anion channel 1 (VDAC1)-mediated transfer of pro-apoptotic Ca2+ signals to mitochondria.
    Monaco G; Decrock E; Arbel N; van Vliet AR; La Rovere RM; De Smedt H; Parys JB; Agostinis P; Leybaert L; Shoshan-Barmatz V; Bultynck G
    J Biol Chem; 2015 Apr; 290(14):9150-61. PubMed ID: 25681439
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nuclear translocation of the pro-apoptotic Bcl-2 family member Bok induces apoptosis.
    Bartholomeusz G; Wu Y; Ali Seyed M; Xia W; Kwong KY; Hortobagyi G; Hung MC
    Mol Carcinog; 2006 Feb; 45(2):73-83. PubMed ID: 16302269
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Selective regulation of IP3-receptor-mediated Ca2+ signaling and apoptosis by the BH4 domain of Bcl-2 versus Bcl-Xl.
    Monaco G; Decrock E; Akl H; Ponsaerts R; Vervliet T; Luyten T; De Maeyer M; Missiaen L; Distelhorst CW; De Smedt H; Parys JB; Leybaert L; Bultynck G
    Cell Death Differ; 2012 Feb; 19(2):295-309. PubMed ID: 21818117
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endoplasmic reticulum stress-induced degradation of DNAJB12 stimulates BOK accumulation and primes cancer cells for apoptosis.
    Sopha P; Ren HY; Grove DE; Cyr DM
    J Biol Chem; 2017 Jul; 292(28):11792-11803. PubMed ID: 28536268
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intrinsic Instability of BOK Enables Membrane Permeabilization in Apoptosis.
    Zheng JH; Grace CR; Guibao CD; McNamara DE; Llambi F; Wang YM; Chen T; Moldoveanu T
    Cell Rep; 2018 May; 23(7):2083-2094.e6. PubMed ID: 29768206
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of inositol 1,4,5-trisphosphate receptors in regulating apoptotic signaling and heart failure.
    Gutstein DE; Marks AR
    Heart Vessels; 1997; Suppl 12():53-7. PubMed ID: 9476544
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HA14-1 potentiates apoptosis in B-cell cancer cells sensitive to a peptide disrupting IP 3 receptor / Bcl-2 complexes.
    Akl H; La Rovere RM; Janssens A; Vandenberghe P; Parys JB; Bultynck G
    Int J Dev Biol; 2015; 59(7-9):391-8. PubMed ID: 26260683
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.